Advanced Micro Devices (NASDAQ: AMD)is one of the leading chipmakers in the world. Its stock has gained 47% since the beginning of this year and 104% in the trailing 52 weeks. To understand the growth trajectory of the stock and its potential future course, it is necessary to have some insights about the company itself. Here, we are breaking it down for you.
Competition and market share
AMD competes mainly with Intel Corporation (NASDAQ: INTC), International Business Machines Corporation (NYSE: IBM), NVIDIA Corporation (NASDAQ: NVDA) and Analog Devices Inc. (NASDAQ: ADI).
Of the four, Intel is the most formidable opponent. The company has a market cap of $198 billion and delivered revenues of $70.8 billion in fiscal-year 2018, with double-digit revenue growth in most of its business units for the year.
IBM had total revenues of $79.6 billion in 2018, though only a small portion of it came from semiconductors. NVIDIA reported total revenues of $11.7 billion for its fiscal year 2019, while Analog Devices posted revenues of $6.2 billion in its latest fiscal year.
According to a report by Jon Peddie Research, in the first quarter of 2019, overall GPU shipments decreased 18.62% from last quarter. Intel saw the biggest drop of over 22%. This was followed by Nvidia (down 12.7%) and AMD (down 4.6%).
AMD’s market share grew by 2.3% from last quarter, while Intel’s decreased by 3.4%. Nvidia’s market share, meanwhile, rose by 1.10%.
Earlier this week, CNBC reported that analysts believe AMD’s new chips, set to release in July, will help it snatch market share from Intel. As per the report, AMD’s third-generation Ryzen chip is said to have outperformed Intel’s CPU by over 16%.
Segments and product line-up
As a semiconductor company, AMD operates its business under two segments – namely Computing and Graphics as well as Enterprise, Embedded and Semi-Custom. The company’s products include x86 microprocessors as an accelerated processing unit (APU) and chipsets, besides discrete and integrated graphics processing units (GPUs). It also provides server and embedded processors, as well as technology for game consoles.
Over the past few quarters, the company has been struggling to drive top line growth as the Computing and Graphics segment, which was the sole contributor till last year, has fallen considerably while the Enterprise, Embedded and Semi-Custom segment showed lackluster performance.
A decline in PC sales and the absence of crypto-related GPU contributed to the falling revenues in the Computing and Graphics segment, which had been displaying a growth streak for 11 consecutive quarters before that. Investors are hoping that the current trend would change by the second half of this fiscal year, as gaming GPU sales return to normal.
In the most recent quarterly results, both the segments were impacted by slower graphics channel sales and lower semi-custom product revenue. This was partly offset by the growth in Ryzen processor sales and datacenter GPU sales. This growth, however, did not meet the anticipated levels.
Financial trend
AMD has a pretty impressive history of beating analysts’ estimates on earnings. In the past five quarters, it has never missed on the bottom-line, and boasts of an average surprise of 11.6%. However, the same cannot be said about the top-line. In the trailing five quarters, the company has twice missed revenue estimates, though both times, it did report a year-over-year growth.
Talking about the topline, the chipmaker has been seeing some deceleration in revenue growth off late, driven by weakness in the Computing and Graphics segment. The company reported a 23% decline in topline in the most recently reported quarter, as revenues from the computing segment plunged 25% year-over-year.
Cash flow situation
AMD’s recovery from negative cash flow that lasted for several years got an impetus after it rolled out the Polaris GPUs a few years ago. More recently, the popular Ryzen and EPYC chips helped the company elevate its cash flows to the positive territory.
AMD recorded cash, cash equivalents and restricted cash of $1.08 billion at the end of 2018, down 9% from last year, reflecting a 44% increase in spending on infrastructure development.
Nevertheless, the company has managed to keep capital spending low when compared to Intel, which outsources most of the production to third-party entities, thereby incurring relatively higher capex that runs into several billion dollars.
LISTEN TO: Advanced Micro Devices Q1 2019 earnings conference call
Though AMD’s operating cash flow increased to $34 million last year from $12 million in 2017, it was not enough to meet the capital requirements. In a sign that the balance sheet is getting stronger, meanwhile, long term debt decreased 16% to $1.1 billion at the end of 2018.
At (-) $275 million, free cash flow remained negative in the March quarter, marking a deterioration from (-) $153 million recorded a year earlier and $79 million in the preceding quarter.
Looking Ahead
For the full year 2019, AMD has reiterated its expectation of high single-digit percentage revenue growth. The upcoming launches of next-generation 7-nanometer Ryzen, EPYC and Radeon datacenter GPU product sales are expected to boost AMD’s market share gains and its financial growth. The company’s ability to lead the roadmap for PC, gaming, and datacenter markets is expected to bear fruit throughout 2019.
AMD views that its top and bottom lines will resume to growth in the back half of 2019. However, investors have to be conscious of the headwinds that are created by the trade war between the US and China. If the trade war doesn’t end before the fall, AMD stock is expected to have a setback.
Most Popular
Agentforce in focus as Salesforce (CRM) gets ready for Q3 2025 earnings
After delivering mixed results in the first half, Salesforce, Inc. (NYSE: CRM) looks poised to report strong numbers when it publishes third-quarter results next week. The Customer relationship management platform
What to look for when Dollar Tree (DLTR) reports Q3 2024 earnings
Shares of Dollar Tree, Inc. (NASDAQ: DLTR) rose over 5% on Monday. The stock has dropped 27% over the past three months. The discount store chain is scheduled to report
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
Comments